Anti-Infectives: How New Research is Shaping Infection Control

Dr. Pankaj Gupta, Senior Medical Director, Pfizer India

In an exclusive interaction with India Pharma Outlook, Dr. Pankaj Gupta, Senior Medical Director at Pfizer India, sheds light on the escalating threat of antimicrobial resistance in India’s ICUs. He discusses evo

Role of Optical Imaging in Early Cancer Detection and Treatment

Dr. Ganesh Babu, Head of Clincal and Regulatory Affairs, Carl Zeiss India

In an interaction with India Pharma Outlook, Dr. Ganesh Babu, Head of Clinical and Regulatory Affairs at Carl Zeiss India, discusses how optical imaging technologies like fluorescence imaging and OCT are revolutionizing cancer detection. He highlight

Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound

Navjot Singh, Executive Director, Trivitron Healthcare

Navjot Singh, Executive Director at Trivitron Healthcare, specializes in medical imaging and healthcare technology. With over two decades of expertise in radiography and ultrasound, he drives innovation and sales. Skilled in leadership, he’s earned a

The Future of Genomic Sequencing: Trends That Will Define the Next Decade

Rami Mehio, VP and Head of Software and Informatics Development, Illumina

In an exclusive interaction with India Pharma Outlook, Rami Mehio, VP and Head of Software and Informatics Development at Illumina, discusses how advanced genetic sequencing is transforming healthcare. He highlights the role of evolving technology,

The Evolution of In-Vitro Diagnostics: Trends and Future Prospects

S. MohanKumar, CEO & Director, Peerless Biotech Pvt. Ltd

S. Mohan Kumar, CEO & Director of Peerless Biotech Pvt. Ltd., in conversation with India Pharma Outlook, shares insights on how diagnostic innovation, particularly point-of-care and molecular diagnostics, is transforming healthcare delivery in India.

Mass Spectrometry in Biomarker Discovery for Early Disease Detection

Nandakumar Kalathil, Country General Manager – India, Agilent Technologies

In an interaction with India Pharma Outlook, Nandakumar Kalathil, AVP Sales India at Agilent Technologies, discusses how high-resolution mass spectrometry is revolutionizing early disease detection in India by enhancing cancer biomarker sensitivity,

© 2025 India Pharma Outlook. All Rights Reserved.